We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

121 hedge funds and large institutions have $277M invested in Voyager Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,056% more call options, than puts

Call options by funds: $194K | Put options by funds: $9K

32% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 37

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.73% less ownership

Funds ownership: 83.23% → 81.5% (-1.7%)

12% less funds holding

Funds holding: 138 → 121 (-17)

36% less capital invested

Capital invested by funds: $430M → $277M (-$153M)

64% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 25

Holders
121
Holders Change
-17
Holders Change %
-12.32%
% of All Funds
2.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
49
Reduced
37
Closed
25
Calls
$194K
Puts
$9K
Net Calls
+$185K
Net Calls Change
-$632K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$7.02M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$3.91M
3
BlackRock
BlackRock
New York
+$3.33M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.66M
5
ClearBridge Investments
ClearBridge Investments
New York
+$2.25M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$6.29M
2
Citadel Advisors
Citadel Advisors
Florida
-$4.39M
3
FCMI
Foresite Capital Management IV
California
-$3.6M
4
UBS AM
UBS AM
Illinois
-$3.21M
5
Millennium Management
Millennium Management
New York
-$3.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
HPC
101
HM Payson & Co
Maine
$21K – – –
Simplex Trading
102
Simplex Trading
Illinois
$19K -$97.6K -8,503 -80%
Zurich Cantonal Bank
103
Zurich Cantonal Bank
Switzerland
$19K – – –
AIP
104
Ameritas Investment Partners
Nebraska
$18K – – –
RA
105
Royce & Associates
New York
$16K +$2.32K +202 +13%
Canada Life
106
Canada Life
Manitoba, Canada
$13K – – –
UBS Group
107
UBS Group
Switzerland
$11K -$106K -9,201 -88%
KPW
108
Kore Private Wealth
New York
$7K – – –
MAM
109
Meeder Asset Management
Ohio
$6K +$5.43K +473 +273%
PAM
110
Panagora Asset Management
Massachusetts
$5K -$88.7K -7,731 -93%
WT
111
Washington Trust
Rhode Island
$5K +$5.74K +500 New
WEC
112
Winslow Evans & Crocker
Massachusetts
$4K – – –
Daiwa Securities Group
113
Daiwa Securities Group
Japan
$2K – – –
ASN
114
Advisory Services Network
Georgia
$2K +$2.52K +220 New
IA
115
IFP Advisors
Florida
$1K – – –
Osaic Holdings
116
Osaic Holdings
Arizona
$1K +$1.37K +119 New
GEA
117
Glen Eagle Advisors
New Jersey
$915 – – –
Squarepoint
118
Squarepoint
New York
– -$1.77M -127,179 Closed
Two Sigma Investments
119
Two Sigma Investments
New York
– -$1M -71,897 Closed
AIMCA
120
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$770K -55,200 Closed
Arrowstreet Capital
121
Arrowstreet Capital
Massachusetts
– -$682K -48,900 Closed
ARTA
122
A.R.T. Advisors
New York
– -$669K -47,987 Closed
Rafferty Asset Management
123
Rafferty Asset Management
New York
– -$612K -43,879 Closed
WG
124
Winton Group
United Kingdom
– -$508K -36,390 Closed
ACM
125
AlphaCrest Capital Management
New York
– -$497K -35,600 Closed
2 3 4
5
6

VYGR Hedge Fund Activity: Q1 2020 in Review

121 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2020, worth a combined $277M — down 36% from $430M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of VYGR and 9 opened new positions — a net loss of 16 holders — while 37 trimmed existing stakes and 49 added.

The largest buyer was Armistice Capital, adding an estimated $7.02M. The largest seller was Federated Hermes, cutting an estimated $6.29M.

  • 121 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2020, down from 138 in Q4 2019.
  • Funds reported $277M of Voyager Therapeutics stock for Q1 2020, down 36% quarter-over-quarter.
  • 9 funds opened new Voyager Therapeutics positions in Q1 2020 and 25 closed out, a net change of -16 holders.
  • The largest Voyager Therapeutics buyer in Q1 2020 was Armistice Capital, an estimated $7.02M added.
  • The largest Voyager Therapeutics seller in Q1 2020 was Federated Hermes, an estimated $6.29M sold.

Based on aggregated 13F filings for Q1 2020.